Back to mobile site

Zimmer Biomet (ZBH) PT Raised to $155 at Needham & Company

January 30, 2018 1:11 PM EST Send to a Friend
Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $144.00) while maintaining a Strong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login